A Special Message From Art Papier, MD, CEO of VisualDx

At VisualDx, we are closely monitoring the COVID-19 pandemic. I want to share with you some important updates surrounding the virus and steps we are taking with our software.

COVID-19 Content and Images

Our VisualDx software system currently includes several images of the pulmonary complications of COVID-19. They include a series of chest radiographs obtained at and several days after admission, as well as on days 8 and 11 after the onset of illness. Bilateral fluffy opacities are present in both images..

We are actively sourcing additional images to help our users understand and visualize pulmonary complications. If you are a VisualDx user at an institution with COVID-19 patients, we would greatly appreciate introductions to your radiologists or attending physicians caring for these patients. We strive to include the spectrum of imagery.

VisualDx also includes regularly updated information and important links to the US Centers for Disease Control and Prevention.

Dual-Use Approach

For 20 years, VisualDx has been used and trusted by frontline healthcare workers to treat infectious diseases. In the time following the September 11 attacks, the US Department of Health and Human Services and the CDC asked our company to develop a website on the smallpox vaccination and its adverse events. From A to Z, anthrax to Zika, VisualDx has been the go-to resource for its approach to emerging symptoms and our dual-use approach.

A dual-use approach is critical because not only do our front-line providers have to tackle COVID-19 but they also must treat all of medicine. After ruling out COVID-19, patients still require timely accurate diagnoses. The VisualDx strategy is to assist clinicians with ALL diagnoses, not just the current crisis.

Our Mission

Our mission at VisualDx is to improve medical decisions around the world. That will not change. Together, we will work to give our patients the best care possible.

Thanks,

Art Papier, MD

CEO, VisualDx